Radioresistance is known to create complications in the treatment of cancer.1 Radiation-induced altered adaptive responses by tumour cells or tissues are considered to be primary reasons behind the failure of radiotherapy.2 Acquirement of radioresistance followed by treatment failure and locoregional recurrence is a multifaceted process. Emerging data have suggested various molecular biomarkers necessitate radioresistance in cancer.

Soft tissue sarcomas (STS) are a group of rare mesenchymal tumours that can arise in patients of any age and in a variety of anatomic sites. It is estimated that STS make up 1% of all adult malignancies and that their incidence is on the rise. The lower limb is the most commonly affected site, with approximately 28% of STS arising there. With at least 50 different histologic subtypes, STS are considered highly heterogenous in terms of their histopathology and their tendency to metastasise. Undifferentiated pleomorphic sarcomas and liposarcomas are the most common histopathologic subtypes in adult patients.

This infographic explores pharmaceutical trade patterns globally, ranking the top importing and exporting countries, spotlighting the manufacturing hotspots to watch, and investigating the impact of COVID-19 on rates of trade internationally.

This review provides a practical update of the role of imaging in every phase throughout the course of ovarian cancer. Read more.

DISTINGUISHING between different conditions of the spine is important in order to provide patients with the correct diagnosis and treatment…

MR-guided focused ultrasound improved delivery of trastuzumab to the brain. Consequently, the drug was able to reduce the size of the tumour…

The Rheumatoid Arthritis in Ongoing Remission (RETRO) study aimed to determine outcomes following tapering and withdrawal…

Consequently, for interferon-β, teriflunomide, and dimethyl fumarate, COVID-19 vaccination is “likely to be effective…”